Medicine:DTaP-IPV-HepB vaccine

From HandWiki
DTaP-IPV-HepB vaccine
Combination of
DTaP vaccineVaccine
Inactivated poliovirus vaccineVaccine
Hepatitis B vaccineVaccine
Clinical data
Trade namesPediarix
AHFS/Drugs.comPediarix
MedlinePlusa607014
License data
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
IM
ATC code
Legal status
Legal status
Identifiers
CAS Number

DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.[2][3][4]

A branded formulation is marketed in the U.S. as Pediarix by GlaxoSmithKline.[5]

References

  1. "Diphtheria, Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Poliovirus (Inactivated) Vaccine". Drugs.com. https://www.drugs.com/ppa/diphtheria-tetanus-toxoids-acellular-pertussis-hepatitis-b-recombinant-and-poliovirus-inactivated-vaccine.html. 
  2. Centers for Disease Control Prevention (CDC) (March 2003). "FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants". MMWR Morb. Mortal. Wkly. Rep. 52 (10): 203–4. PMID 12653460. 
  3. Centers for Disease Control Prevention (CDC) (October 2008). "Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose". MMWR Morb. Mortal. Wkly. Rep. 57 (39): 1078–9. PMID 18830212. 
  4. "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices". MMWR Recomm Rep 67 (1): 1–31. January 2018. doi:10.15585/mmwr.rr6701a1. PMID 29939980. 
  5. "Pediarix". 21 February 2018. https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix.